Vanguard Personalized Indexing Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Buy |
11,678
+1,921
| +20% | +$291K | 0.02% | 611 |
|
|
2025
Q1 | $1.47M | Buy |
9,757
+1,752
| +22% | +$264K | 0.02% | 610 |
|
|
2024
Q4 | $1.48M | Buy |
8,005
+442
| +6% | +$81.6K | 0.02% | 591 |
|
|
2024
Q3 | $1.49M | Sell |
7,563
-623
| -8% | -$123K | 0.02% | 580 |
|
|
2024
Q2 | $1.69M | Buy |
8,186
+628
| +8% | +$129K | 0.03% | 464 |
|
|
2024
Q1 | $2.05M | Buy |
7,558
+242
| +3% | +$65.6K | 0.04% | 389 |
|
|
2023
Q4 | $1.73M | Buy |
7,316
+1,080
| +17% | +$255K | 0.04% | 390 |
|
|
2023
Q3 | $1.22M | Sell |
6,236
-362
| -5% | -$70.9K | 0.04% | 471 |
|
|
2023
Q2 | $1.39M | Buy |
6,598
+114
| +2% | +$24K | 0.04% | 427 |
|
|
2023
Q1 | $1.31M | Buy |
6,484
+738
| +13% | +$149K | 0.05% | 414 |
|
|
2022
Q4 | $1.25M | Buy |
5,746
+194
| +3% | +$42.3K | 0.05% | 418 |
|
|
2022
Q3 | $1.09M | Buy |
5,552
+381
| +7% | +$75K | 0.05% | 438 |
|
|
2022
Q2 | $1.11M | Sell |
5,171
-23
| -0.4% | -$4.92K | 0.05% | 415 |
|
|
2022
Q1 | $1.48M | Sell |
5,194
-125
| -2% | -$35.5K | 0.07% | 276 |
|
|
2021
Q4 | $2M | Sell |
5,319
-731
| -12% | -$275K | 0.12% | 164 |
|
|
2021
Q3 | $2.5M | Sell |
6,050
-354
| -6% | -$146K | 0.22% | 83 |
|
|
2021
Q2 | $2.37M | Buy |
6,404
+1,966
| +44% | +$727K | 0.25% | 75 |
|
|
2021
Q1 | $1.29M | Buy |
+4,438
| New | +$1.29M | 0.19% | 107 |
|